Concordance between severity of disease, disability and health-related quality of life in Myasthenia gravis

Neurological Sciences

Volumn 31, Issue 1, 2010, Pages 41-45

  Raggi, Alberto ^a   Leonardi, Matilde ^a   Antozzi, Carlo ^b   Confalonieri, Paolo ^b   Maggi, Lorenzo ^b   Cornelio, Ferdinando ^b   Mantegazza, Renato ^b  

^a IRCCS   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Disability; Health related quality of life; International Classification of Functioning, Disability and Health; Myasthenia gravis; WHO DAS II

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PHYSICAL DISABILITY; PSYCHOLOGICAL MODEL; QUALITY OF LIFE; REMISSION; SHORT FORM 36; SOCIAL PSYCHOLOGY;

CLUSTER ANALYSIS; DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 76449111965     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-009-0167-y     Document Type: Article

References (26)

1. BM Conti-Fine M Milani HJ Kaminski 2006 Myasthenia gravis: past, present, future J Clin Invest 116 2843 2854 10.1172/JCI29894 (Pubitemid 44684466)
2. A Jaretzki 3rd RJ Barohn RM Ernstoff HJ Kaminski JC Keesey AS Penn DB Sanders 2000 Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America Neurology 55 16 23 10891897
3. A Vincent J Palace D Hilton-Jones 2001 Myasthenia Gravis Lancet 357 2122 2128
4. R Mantegazza F Baggi C Antozzi P Confalonieri L Morandi P Bernasconi F Andreetta O Simoncini A Campanella E Beghi F Cornelio 2003 Myasthenia gravis (MG): epidemiological data and prognostic factors Ann N Y Acad Sci 998 413 423 10.1196/annals.1254.054 14592909 (Pubitemid 37194193)
5. RJ Barohn D Mcintire L Herbelin GI Wolfe S Nations W Bryan 1998 Reliability testing of the quantitative myasthenia gravis score Ann NY Acad Sci 941 769 772 10.1111/j.1749-6632.1998.tb11015.x (Pubitemid 28362935)
6. L Pauda A Evoli I Aprile P Caliandro S Mazza R Padua P Tonali 2001 Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements Neurol Sci 22 363 369 10.1007/s100720100066
7. RH Paul J Nash RA Cohen JM Gilchrist JM Goldstein 2001 Quality of life and well-being of patients with myasthenia gravis Muscle Nerve 24 512 516 10.1002/mus.1034 (Pubitemid 32246787)
8. L Padua A Evoli I Aprile P Caliandro P D'Amico A Rabini P Tonali 2002 Quality of life in patients with myasthenia gravis Muscle Nerve 25 466 467 10.1002/mus.10035 (Pubitemid 34203229)
9. A Rostedt L Padua EV Stålberg 2006 Correlation between regional myasthenic weakness and mental aspects of quality of life Eur J Neurol 13 191 193 10.1111/j.1468-1331.2006.01149.x
10. A Rostedt L Padua EV Stalberg 2005 Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in Myasthenia Gravis patients Clin Neurophysiol 116 2058 2064 10.1016/j.clinph.2005.05.017 16043394 (Pubitemid 41262196)
11. KR Scott MJ Kothari 2006 Self-reported pain affects quality of life in Myasthenia Gravis J Clin Neuromusc Dis 7 110 114 10.1097/01.cnd.0000202223. 39994.c0 (Pubitemid 44510077)
12. S Happe G Klosch J Zeitlhofer 2004 Perception of dreams and subjective sleep quality in patients with myasthenia gravis Neuropsychobiology 50 21 27 10.1159/000077937 15179016 (Pubitemid 38721165)
13. DB Sanders IK Hart R Mantegazza SS Shukla ZA Siddiqi MH De Baets A Melms MW Nicolle N Solomons DP Richman 2008 An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis Neurology 71 400 406 10.1212/01.wnl.0000312374.95186.cc
14. A Rostedt L Padua EV Stalberg 2006 Validation of the Swedish version of the disease-specific Myasthenia Gravis Questionnaire Neurol Sci 27 91 96 10.1007/s10072-006-0606-y (Pubitemid 43983244)
15. L Padua G Galassi A Ariatti I Aprile P Caliandro A Evoli C Pazzaglia P Tonali 2005 Myasthenia gravis self-administered questionnaire: development of regional domains Neurol Sci 25 331 336 10.1007/s10072-004-0366-5 (Pubitemid 40347911)
16. LL Mullins MY Carpentier RH Paul DB Sanders Muscle Study Group 2008 Disease-specific measure of quality of life for Myasthenia Gravis Muscle Nerve 38 947 956 10.1002/mus.21016 18697209
17. TM Burns MR Conaway GR Cutter DB Sanders Muscle Study Group 2008 Less is more, or almost as much: a 15-item quality of life instrument for myasthenia gravis Muscle Nerve 38 957 963 10.1002/mus.21053 18642357
18. M Leonardi J Bickenbach TB Ustun N Kostanjsek S Chatterji MHADIE Consortium 2006 The definition of disability: what is in a name? Lancet 368 1219 1221 10.1016/S0140-6736(06)69498-1 17027711 (Pubitemid 44485780)
19. World Health Organisation (2001) The international classification of functioning, disability and health-ICF. WHO, Geneva
20. G Apolone P Mosconi 1998 The Italian SF-36 health survey: translation, validation and norming J Clin Epidemiol 51 1025 1036 10.1016/S0895-4356(98) 00094-8 (Pubitemid 28527158)
21. Ustun TB (1999) WHO-DAS II Field Trials Report 1998. WHO, Geneva
22. RS Bedlack DL Simel H Bosworth B Samsa B Tucker-Lipscomb DB Sanders 2005 Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity Neurology 64 1968 1970 10.1212/01.WNL.0000163988.28892.79 (Pubitemid 40800720)
23. R Mantegazza C Antozzi D Peluchetti A Sghirlanzoni F Cornelio 1988 Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis J Neurol 255 449 453 10.1007/BF00314245 (Pubitemid 18262976)
24. T Sharshar S Chevret M Mazighi P Chillet G Huberfeld C Berreotta M Houfani P Gajdos 2000 Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis J Neurol 247 286 290 10.1007/s004150050585
25. GI Wolfe LR Herbelin SP Nations B Foster WW Bryan RJ Barohn 1999 Myasthenia gravis activities of daily living profile Neurology 52 1487 1489
26. L Vanderveldea PYK Van den Bergh N Goemans JL Thonnard 2007 ACTIVLIM: a Rash-built measure of activity limitations in children and adults with neuromuscular disorders Neuromuscul Disord 17 459 469 10.1016/j.nmd.2007.02.013 (Pubitemid 46783448)